NCT04987827View on ClinicalTrials.gov

Investigating the Clinical Features and Prognosis of Bronchiectasis Adult Patients

UnknownOBSERVATIONAL
Enrollment

1,250

Participants

Timeline

Start Date

November 1, 2021

Primary Completion Date

April 30, 2022

Study Completion Date

June 30, 2023

Conditions
Bronchiectasis Adult
Interventions
OTHER

No intervention

No intervention

Trial Locations (1)

200025

Ruijin Hospital, Medical School of Shanghai Jiaotong University, Shanghai

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Ruijin Hospital

OTHER